By Monica Heger
Korean genomic services provider Macrogen has expanded its sequencing fleet and plans to begin offering a clinical sequencing service for cancer by next year.
The company recently ordered 10 Illumina HiSeq 2000s and two MiSeqs. It plans to upgrade several of the new HiSeqs to the HiSeq 2500 when that system is commercially available later this year. Macrogen also has several SOLiD and 454 GS FLX platforms in place already, as well as three Ion Torrent PGMs.